The assessment of endothelial function in the cardiac catheterization laboratory in patients with risk factors for atherosclerotic coronary artery disease

Herz

Volumn 24, Issue 7, 1999, Pages 544-547

  Hasdai, David ^a   Lerman, Amir ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b MAYO CLINIC   (United States)

Author keywords

Arteriosclerosis; Endothelium; Risk factors; Vasomotion

Indexed keywords

BLOOD VESSEL TONE; CELL GROWTH; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; HEART CATHETERIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; REVIEW; RISK FACTOR; THROMBOCYTE AGGREGATION;

EID: 0032734355     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044226     Document Type: Review

References (20)

1. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999;34:631-8.
2. Celermeyer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-55.
3. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-34.
4. Egashira K, Hirooka Y, Kai H, et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-24.
5. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle cell by acetylcholine. Nature 1980;288:373-6.
6. Hasdai D, Cannan CR, Mathew V, et al. Evaluation of patients with minimally obstructive coronary artery disease and angina. Int J Cardiol 1996;53:203-8.
7. Hasdai D, Gibbons RJ, Holmes DR Jr, et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390-5.
8. Hasdai D, Holmes DR Jr, Higano ST, el al. Prevalence of coronary blood flow reserve abnormalities among patients with non-obstructive coronary artery disease and chest pain. Mayo Clin Proc 1998;73:1133-40.
9. Johnstone MT, Creager SJ, Scales KM, et al. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-6.
10. Leung W-H, Erl W, Weber K, et al. Beneficial effects of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993; 341:1496-1500.
11. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
12. Mathew V, Cannan CR, Miller VM, et al. Enhanced endothelin mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. Circulation 1997;96:1930-6.
13. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and -independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologica 1992;35:771-6.
14. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
15. Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
16. Seiler C, Hess OM, Buechi M, et al. Influence of serum cholesterol and other risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1991; 88:2139-48.
17. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
18. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose controls with metformin on complications in over-weight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
19. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to its risk factors for coronary artery disease. Circulation 1990;81:491-8.
20. Zilla P, von Oppell U, Deutsch M. The endothelium: a key to the future. J Card Surg 1993;8:32-60.